Latest News:

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

News
Radio Show
- Be on our Show!
- Video Interviews
Technology
Cannabis
Energy
BioTech
Mining
Contact Us
- About Us
- Suggestion Box

Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

SILO

Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

January 13, 2021January 13, 2021 Stock Day Media 68 Views Baltimore, centralnervoussystem, Maryland, multiplescelrosis, psilocybin, SILO, silopharmainc

Silo Pharma could Utilize Data for Psilocybin Delivery potential to Central Nervous System Englewood Cliffs, NJ, Jan. 13, 2021 (GLOBE

Read more

Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

January 11, 2021January 11, 2021 Stock Day Media 84 Views cancer, cancerapplications, patentlicense, psilocybin, SILO, silopharma

Englewood Cliffs, NJ, Jan. 11, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

Read more

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

January 6, 2021January 6, 2021 Stock Day Media 113 Views applications, Pharma, psilocybincancer, SILO, silopharmainc, therapeutic

Englewood Cliffs, NJ, Jan. 06, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

Read more

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal

Copyright © 2021 Stock Day Media. All rights reserved.